ATHE
Alterity Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · AU
$3.91
+4.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.34x
- Price / sales
- —
- Price / cash flow
- -4.31x
Enterprise value
- Enterprise value
- $44.8M
- EV / sales
- —
- EV / EBITDA
- -2.23x
- EV / EBIT
- -2.22x
- Market cap
- $71.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026